Bevacizumab and Capecitabine in Treatment of Elderly Patients With Metastatic Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Metastasis
Interventions: DRUG: Capecitabine and Bevacizumab
Sponsor: South Eastern European Research Oncology Group
Collaborators: Roche Pharma AG